Skip to main content
Clinical Trials/CTRI/2023/01/048819
CTRI/2023/01/048819
Not yet recruiting
未知

Prospective, Observational Study of Novel Biomarkers bio-ADM & penKid for prediction of manifestation of Sepsis related Multiorgan Failure or Shock and to monitor Severity & Outcomes in Patients with Sepsis

Rivaara Labs Pvt. Ltd.0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Rivaara Labs Pvt. Ltd.
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
Rivaara Labs Pvt. Ltd.

Eligibility Criteria

Inclusion Criteria

  • Subjects with clinically suspected sepsis admitted in ICU
  • 1\. Above18 years of age
  • 2\. Expected ICU stay of more than 24 hrs

Exclusion Criteria

  • 1\. Age below 18 years
  • 2\. Pregnant or lactating mothers
  • 3\. Terminal stage disease

Outcomes

Primary Outcomes

Not specified

Similar Trials